US Biotest, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2000-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.usbiotest.com
Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
- First Posted Date
- 2021-03-02
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04778059
- Locations
- 🇺🇸
The University of Arizona Health Sciences Center/ Banner Healthcare Systems Hospitals, Tucson, Arizona, United States
Study of the Safety of USB005 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2019-04-04
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03615196
- Locations
- 🇺🇸
WCCT Global, Inc., Cypress, California, United States
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2012-09-27
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT00796744
- Locations
- 🇺🇸
Southern Arizona Limb Salvage Alliance (SALSA), Tucson, Arizona, United States
🇺🇸Georgetown University Medical Center, Georgetown, Maryland, United States
🇺🇸Renaissance Hospital Dallas, Dallas, Texas, United States
Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2012-02-29
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT00757250
- Locations
- 🇺🇸
LAC+USC Medical Center, Rand Schrader Clini, Los Angeles, California, United States
🇺🇸UCSD Division of Infectious Diseases, San Diego, California, United States
🇺🇸Harbor - UCLA Medical Center, Torrance, California, United States
© Copyright 2024. All Rights Reserved by MedPath